Marsel Mesulam
Affiliations: | Northwestern University, Evanston, IL |
Website:
http://www.northwestern.edu/nuin/fac/mesulam.htmGoogle:
"Marsel Mesulam"Mean distance: 12.77 (cluster 23) | S | N | B | C | P |
Children
Sign in to add trainee
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Arseni D, Nonaka T, Jacobsen MH, et al. (2024) Heteromeric amyloid filaments of ANXA11 and TDP-43 in FTLD-TDP Type C. Nature |
Arseni D, Nonaka T, Jacobsen MH, et al. (2024) Heteromeric amyloid filaments of ANXA11 and TDP-43 in FTLD-TDP Type C. Biorxiv : the Preprint Server For Biology |
Pottier C, Küçükali F, Baker M, et al. (2024) Deciphering Distinct Genetic Risk Factors for FTLD-TDP Pathological Subtypes via Whole-Genome Sequencing. Medrxiv : the Preprint Server For Health Sciences |
Rajabli F, Benchek P, Tosto G, et al. (2023) Multi-ancestry genome-wide meta-analysis of 56,241 individuals identifies and nominates ancestry-specific loci , , and as novel risk loci for Alzheimer's disease: the Alzheimer's Disease Genetics Consortium. Medrxiv : the Preprint Server For Health Sciences |
Nassan M, Piras IS, Rogalski E, et al. (2023) Evaluating the Association Between Genetically Proxied Neurodevelopmental Language Phenotypes and the Risk for Primary Progressive Aphasia. Neurology |
Kawles A, Minogue G, Zouridakis A, et al. (2023) Differential vulnerability of the dentate gyrus to tauopathies in dementias. Acta Neuropathologica Communications. 11: 1 |
Mesulam M, Thompson C, Weintraub S, et al. (2022) The Wernicke conundrum is misinterpreted. Brain : a Journal of Neurology |
Martersteck A, Ayala I, Ohm DT, et al. (2022) Focal amyloid and asymmetric tau in an imaging-to-autopsy case of clinical primary progressive aphasia with Alzheimer disease neuropathology. Acta Neuropathologica Communications. 10: 111 |
Roberts AC, Rademaker AW, Salley EA, et al. (2022) Communication Bridge™-2 (CB2): an NIH Stage 2 randomized control trial of a speech-language intervention for communication impairments in individuals with mild to moderate primary progressive aphasia. Trials. 23: 487 |
Mesulam MM, Coventry CA, Bigio EH, et al. (2022) Neuropathological fingerprints of survival, atrophy and language in primary progressive aphasia. Brain : a Journal of Neurology |